Skip to main content

Table 2 Relationship between ABO/RH blood group and SARS-CoV-2 infection among 343 blood donors from Luanda, Angola

From: Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola

Independent variables

N (%)

Anti-SARS-CoV-2 positivity

Past infection

Recent infection

Univariate analysis

  

No (%)

Yes (%)

p-value*

No (%)

Yes (%)

p-value*

No (%)

Yes (%)

p-value*

OR (95% CI)

p-value

ABO blood group

            

A

61 (17.8)

57 (93.4)

4 (6.6)

0.075

59 (96.7)

2 (3.3)

0.023

59 (96.7)

2 (3.3)

0.174

2.12 (0.60–7.48)

0.245

B

54 (15.7)

51 (94.4)

3 (5.6)

 

53 (98.1)

1 (1.9)

 

52 (96.3)

2 (3.7)

 

1.77 (0.44–7.10)

0.418

AB

10 (2.9)

8 (80.0)

2 (20.0)

 

8 (80.0)

2 (20.0)

 

10 (100)

0 (0.0)

 

7.54 (1.35–42.2)

0.022

O

218 (63.6)

211 (96.8)

7 (3.2)

 

212 (97.2)

6 (2.8)

 

217 (99.5)

1 (0.5)

 

1.00

RH blood group

            

RH–

9 (2.6)

8 (88.9)

1 (11.1)

0.353

9 (100)

0 (0.0)

0.580

8 (88.9)

1 (11.1)

0.014

2.66 (0.31–22.7)

0.371

RH + 

334 (97.4)

319 (95.5)

15 (4.5)

 

323 (96.7)

11 (3.3)

 

330 (98.8)

4 (1.2)

 

1.00

ABO/RH blood group

           

ARh + 

58 (16.9)

55 (94.8)

3 (5.2)

0.033

56 (96.6)

2 (3.4)

0.081

57 (98.3)

1 (1.7)

 < 0.001

1.00

ARh–

3 (0.9)

2 (66.7)

1 (33.3)

 

3 (100)

0 (0.0)

 

2 (66.7)

1 (33.3)

 

9.17 (0.64–132)

0.103

BRh + 

54 (15.7)

51 (94.4)

3 (5.6)

 

53 (98.1)

1 (1.9)

 

52 (96.3)

2 (3.7)

 

1.08 (0.21–5.59)

0.928

BRh–

0 (0.0)

0 (0.0)

0 (0.0)

 

0 (0.0)

0 (0.0)

 

0 (0.0)

0 (0.0)

 

ABRh + 

10 (2.9)

8 (80.0)

2 (20.0)

 

8 (80.0)

2 (20.0)

 

10 (100)

0 (0.0)

 

4.58 (0.66–31.8)

0.123

ABRh–

0 (0.0)

0 (0.0)

0 (0.0)

 

0 (0.0)

0 (0.0)

 

0 (0.0)

0 (0.0)

 

ORh + 

212 (61.8)

205 (96.7)

7 (3.3)

 

206 (97.2)

6 (2.8)

 

211 (99.5)

1 (0.5)

 

0.63 (0.16–2.50)

0.507

ORh–

6 (1.7)

6 (100)

0 (0.0)

 

6 (100)

0 (0.0)

 

6 (100)

0 (0.0)

 

0 (0.0–0.0)

0.999

  1. Past infection (IgG+/IgM−) and Recent infection (IgG−/IgM+ or IgG+/IgM+)
  2. The bold numbers were statistically significant (p < 0.05)
  3. *Chi-square test (X2)